Zghaib et al; Multimodal Evaluation of Scar in ARVC
A rrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy presenting with regional dysfunction and enlargement of the right ventricle (RV). 1 Histologically, there is fibrofatty replacement of the myocardium. 2 Diagnosis is challenging and is currently based on the Task Force Criteria (TFC), including imaging, to detect RV global and regional dysfunction and enlargement. 3 Ventricular arrhythmias characteristic of the disease ranges from premature ventricular beats to ventricular tachycardia (VT) and fibrillation. 2, 4 Indeed, fibrofatty replacement progresses from epicardium to endocardium and serves as a substrate for reentry. 5 Electroanatomic mapping (EAM) performed as part of an EPS (Electrophysiological Study) is an important diagnostic tool to rule out mimicking conditions like idiopathic VT and a therapeutic tool to guide lesion placement during VT ablation. 6 Nonetheless, EPS is invasive, can only be done in an electrophysiological laboratory, and requires anesthesia. Cardiac magnetic resonance imaging (CMR) is a promising technique for delineation of RV anatomy and function as well as for characterizing the composition of the RV wall, especially with regard to the presence of fibrosis and fatty tissue. 7, 8 Indeed, myocardial late gadolinium enhancement (LGE) after intravenous administration of a gadolinium-based contrast agent has been shown to correlate with histopathology and predict inducible VT in patients with ARVC. 8 In recently published work, we have shown the feasibility and reproducibility of feature tracking-based regional RV strain analysis on cine CMR for the diagnosis of ARVC. 9 However, the correlation between these techniques in delineating arrhythmogenic substrate in RV is unknown.
In this study, we sought to examine and compare VT substrate using different modalities (regional strain on cine CMR, LGE imaging, and electroanatomical voltage mapping) in ARVC patients presenting for VT ablation.
METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Patient Population
Twenty-one patients with ARVC presenting to the Johns Hopkins Hospital for VT ablation were retrospectively selected based on availability of CMR acquired no >12 months before the procedure. Patients with implanted devices at the time of CMR acquisition were excluded because of significant artifact which precludes proper strain analysis. All selected patients had undergone comprehensive clinical evaluation to confirm the presence of diagnostic TFC for ARVC. 3 All subjects provided written informed consent to be included in research, and the study was approved by our institutional review board.
Magnetic Resonance Imaging Acquisition
Cine images in the short-axis planes were acquired at 1.5 T (Avanto, Siemens Medical Imaging, Erlangen, Germany) using a balanced, steady-state free precession sequence (repetition time [ 3 ; field of view, 30-36 cm; temporal resolution, ≤40 ms; slice thickness, 6-8 mm). In-plane axial resolution ranged from 0.8 to 1.5 mm per dimension. Delayed enhancement images were acquired at end diastole during breath-holding using a segmented inversion-recovery gradient-echo turbo fast low angle shot sequence obtained 10 to 15 minutes after injection of 0.2 mmol/kg of gadopentetate dimeglumine (Magnevist, Bayer) contrast medium. Images were visually scored for the presence or absence of LGE by consensus of 2 experienced readers in ARVC imaging (S. Zimmerman and I. Kamel).
Strain Analysis
Cardiac MR analysis was done in a blinded fashion to the findings of the EP study. For global metrics, RV and left ventricular (LV) ejection fraction (EF), end-systolic volume, and end-diastolic volume were measured with CVI42 (Circle Cardiovascular Imaging; Client Version 248, Server Version 258; Calgary, Alberta, Canada). RV end-systolic volume and end-diastolic volume were indexed to body surface area using the Dubois formula (body surface area=body weight (kg)
CLINICAL PERSPECTIVE
The 2010 Task Force Criteria for arrhythmogenic right ventricular cardiomyopathy diagnosis, which rely on visual inspection of right ventricular abnormalities, may be incorrectly applied in centers lacking experience. Quantitative cardiac magnetic resonance imaging-based strain analysis has higher sensitivity and accuracy than qualitative visual assessment to detect regional right ventricular abnormalities and is thus better able to objectively rule out arrhythmogenic right ventricular cardiomyopathy mimics. EPS (Electrophysiological Study) is performed to diagnose arrhythmogenic right ventricular cardiomyopathy and map arrhythmogenic substrate in patients with ventricular arrhythmias, but the invasiveness of the procedure warrants investigating new modalities that do not carry the same inherent risks to the patient. This study demonstrates that arrhythmia substrate can be assessed noninvasively using tissue tracking on cine cardiac magnetic resonance imaging, allowing preprocedural recognition of the spatial distribution of electrophysiological scar and helping to focus mapping on the culprit regions. In contrast, late gadolinium enhancement displays limited agreement with electroanatomic mapping in right ventricle and thus possesses limited capabilities in detecting arrhythmogenic scar in patients with arrhythmogenic right ventricular cardiomyopathy. ×0.007184). For regional analysis, we measured peak circumferential strain using Multimodality Tissue Tracking software (MTT Version 6.0.4725; Toshiba Medical Systems Corporation, Tokyo, Japan). 10 On short-axis views, the most basal slice without right atrium through-plane motion during systole, a mid-RV slice, and an apical slice were selected for stain analysis. Endocardial and epicardial contours were drawn in a semiautomated manner from anterior to inferior RV insertion points. RV was segmented into outflow tract, free wall, angle, and inferior regions in basal and mid-RV cuts and into free wall and inferior segments at the apex. The segmentation of the RV at various levels is illustrated in Figure 1 . Contours were based on spline curves, the order of which is defined internally by the manufacturer. Points along the contour at end diastole were used to define a 10×10 mm neighborhood, which was matched to a neighborhood of the subsequent frame within a search window by minimizing the sum of squared differences between pixel intensities. The quality of tracking was visually verified and manually adjusted if necessary. By convention for strain, segmental shortening is negative. Interobserver reproducibility was measured using a randomly selected sample of 10 cases by 2 independent observers.
Mapping Procedure
Informed written consent was obtained before all procedures. For all intracardiac electrophysiology studies, vascular access was obtained via femoral veins in a sterile fashion using the modified Seldinger technique. Detailed mapping of the RV endocardium was created in all patients in sinus rhythm using the CARTO system (Biosense Webster, Diamond Bar, CA) and either a 3.5-mm externally irrigated catheter (ThermoCool SF, Biosense Webster) or a 20-pole PentaRay NAV (Biosense Webster) catheter. The voltage data were reviewed during the procedure to ensure appropriate signal quality. Pericardial access was obtained anteriorly by marking 2 cm below the xiphoid process. An epidural needle was advanced under fluoroscopy in lateral and PA views ensuring to enter beneath the xiphoid process. Contrast (2-3 cc) was injected which outlined the pericardial space. The needle was further advanced until it traversed the pericardial space. A Bentson wire was advanced with circumferential looping of the wire to confirm its presence in the pericardial space. The wire was exchanged with a 0.035-floppy J-wire, and a short steerable sheath was then advanced over the J-wire. Mapping catheter was advanced into the pericardial through the steerable sheath where highdensity mapping was repeated epicardially. Electrograms were band passed filtered at 2 to 240 Hz for unipolar recordings and at 16 to 500 Hz for bipolar recordings.
Ablation Strategy
Our ablation strategy has been previously described. 11 In brief, target VTs were clearly defined at the beginning of the procedure by an EPS including administration of high-dose isoproterenol. 12 Pace maps were obtained from the regions of late potentials and correlated with induced VTs. The arrhythmia was subsequently induced, and critical isthmus was defined with entrainment mapping. Ablation was performed either during VT (for stable VT) or during sinus rhythm in the case of unstable VTs. Radiofrequency energy output with the 3.5-mm irrigated catheter was set to 20 to 30 W in the epicardium and 40 to 50 W in the endocardium. All regions of late potentials were systematically targeted and ablated. Ablation was guided by significant (>10 Ω) impedance drop during the ablation or by the inability to capture using 10 V at 2 ms after the ablation. During the waiting period of 30 to 90 minutes, programmed stimulation with up to 3 ventricular extra-stimuli was delivered from 2 different RV sites. Furthermore, isoproterenol was infused at a rate of 5 µg/min and incrementally increased to 30 µg/min at 2-minute intervals as tolerated. At peak tolerated doses, rapid burst pacing was performed. At the end of the procedure, 125 mg methylprednisolone sodium succinate was injected into the pericardial space, and all patients were given scheduled ketorolac for 1 to 2 days. Antiarrhythmic drugs were discontinued after catheter ablation unless the patient had frequent ventricular ectopy or recurrent VT.
Statistical Analysis
Continuous and discrete data are presented as mean (±SD), median [interquartile range], and n (%), respectively. Illustration of the segmentation of the RV on various short-axis levels. Endocardial and epicardial contours were drawn in a semiautomated manner from the anterior to the inferior RV insertion points. RV was segmented into outflow tract (1), free wall (2), angle (3), and inferior regions (4) in basal and mid-RV cuts and into free wall and inferior segments at the apex. LV indicates left ventricle.
Interobserver reliability, or intraclass correlation coefficient and its 95% confidence intervals, was calculated using a 2-way mixed-effects model. The association between endocardial and epicardial dense scar (<0.5 mV) on EAM as the dependent variables with clinical characteristics and regional strain absolute values as independent variables was examined using multilevel multivariable logistic regression models, clustered by patient. To avoid collinearity, correlations between continuous variables by chamber (RV and LV) were tested using the Pearson Correlation Coefficient before fitting any 2 independent variables in the same model. Among the pool of collinear variables, the parameters with the strongest association with the outcome were selected using Akaike information criterion for inclusion in the multivariable model. Agreement between LGE and EAM scar assessment was evaluated by κ analysis, whereas LGE versus strain analysis was evaluated using patientclustered logistic regression. Two-sided P value <0.05 were considered statistically significant. Statistical analysis was performed using STATA software (version 13; StataCorp, College Station, TX).
RESULTS

Patient Characteristics
Clinical characteristics of the patients are shown in Table 1 . Average age at ablation was 30.2±9.9 years, 57% of patients were female, and mean body mass index was 25.4±5.4 kg/m 2 . Ten patients (48%) had the desmosomal-PKP2 mutation, whereas the remaining 11 patients were found to carry no pathological mutation.
Strain Analysis
On average, CMR study was performed 3.2 months [0-8.1 months] before the procedure. Mean RV end-diastolic volume index was 163.7±71.5 mL/m 2 , mean RVEF was 40.6±7.9%, and LVEF was 60.5±5.8%. Regional analysis included 210 ventricular segments (10 per patient) as described above. Mean circumferential strain by anatomic regions is summarized in Table 2 . Overall, mean circumferential strain was −9.2±3.0% at the RV base, −7.3±3.4% at the mid-RV, and −11.5±3.8% at the apex. Interobserver reproducibility was found to be excellent using a 2-way mixed-effects model (intraclass correlation coefficient, 0.87; 95% confidence interval, 0.81-0.91; P<0.001). We previously showed excellent reproducibility of strain measurement within and between observers using the same methodology. 
Voltage Mapping
Endocardial mapping was performed in all cases and epicardial mapping in 17 patients. Endocardial dense scar (defined as <0.5 mV) was detected in 17 (81%) patients and epicardial dense scar in 16 (94%) patients. As seen in Table 3 , scar was most commonly located at the RV base (angle, inferior aspect, and outflow tract) on both endo-and epicardial mapping. Sixty-two percent of patients had inducible VT with 33 different morphologies. At the end of the procedure, VT was noninducible in all cases. Distribution of VT culprit sites (defined as ablation sites with VT termination) is included in Table 3 . No major or minor complications were reported. 
Strain EAM Correlation
Segments with EAM scar had lower mean strain compared to segments without scar both endocardially and epicardially (−9.7±4. 
LGE Analysis
Late gadolinium enhanced imaging was performed in 17 (81%) participants. RV-LGE was found in 3 (18%) of 17 patients, in a total of 15 segments: 1 (7%) in the basal free wall, 4 (27%) in the inferobasal region, 3 (20%) in the mid-RVOT, 6 (40%) in the mid-inferior region, and 1 (7%) in the apex. Mean strain was significantly lower in LGE areas (−9.9±4.4 versus −6.0±3.6; P=0.001), and each unit increase in strain was associated with a 43% decrease in odds of colocalized LGE scar (OR, 0.58; P=0.003).
There was modest agreement between endocardial EAM and LGE on scar assessment (κ=0.18; n=21; P=0.004). Mismatch was found in 36 (21%) segments, with 28 EAM scars not confirmed by LGE and 8 LGE scars undetected by endocardial EAM. No association was found between epicardial EAM and LGE scars (κ=0.06; n=13; P=0.24). We have performed a multivariable analysis of the association between LGE scar with endocardial and epicardial EAM scar. As seen in Table II in the Data Supplement, presence of LGE scar was significantly associated with presence of endocardial EAM scar (OR, 11.3; P=0.021; n=17 patients/170 segments) after adjusting for age at ablation, body mass index, genotype, RV indexed end-diastolic volume, and LVEF. In a similar adjusted model, presence of LGE scar was not associated with epicardial EAM scar (OR, 2.6; P=0.20; n=13 patients/130 segments). LGE poorly correlated with VT culprit sites as 45 (85%) of 53 VT culprit sites were found to be LGE free (P=0.06). Measurements are reported as n (%). Endocardial Mapping was performed in 21 patients, whereas epicardial mapping was performed in 17 patients. VT ablation was performed in all 21 patients. VT indicates ventricular tachycardia.
DISCUSSION
In this study, we examine the arrhythmogenic substrate in the RV of patients with ARVC presenting to our institution for VT ablation using a multimodal approach: regional strain analysis on cine CMR, late gadolinium enhancement imaging, and invasive electroanatomical endocardial and epicardial voltage mapping. Main findings are (1) strain was significantly lower in segments with dense scar compared with those without dense scar on endocardial and epicardial voltage mapping, and lower CMR strain was associated with increased odds of harboring endocardial and epicardial dense scar as well as VT culprit sites; (2) strain was significantly lower in segments with LGE compared with those without LGE, and lower CMR strain was associated with increased odds of harboring LGE scar; and (3) LGE correlated poorly with EAM scar on endocardial mapping and did not correlate with epicardial scar or successful ablation sites.
Regional Strain Analysis
Using quantitative metrics, we assessed regional RV myocardial strain through CMR feature tracking. We have previously shown that global strain was significantly lower in ARVC compared with control subjects and that regional strain at the subtricuspid area showed the greatest differences between the 2 groups with good sensitivity and specificity. 9 Prati et al 13 also found that ARVC patients had lower RV global longitudinal, circumferential, and radial strain compared with patients with idiopathic RV outflow tract VT and controls. Similarly, Heermann et al 14 found that global RV longitudinal strain rates and circumferential strain and strain rates at the basal level were significantly lower in ARVC patients compared with controls. To the best of our knowledge, we are the first to quantitatively demonstrate inverse association between regional RV myocardial strain with dense scar on endo-and epicardial EAM in ARVC.
Reproducibility of Strain Analysis
Prior ARVC studies have measured RV strain using different software methods. Our group has recently assessed the reproducibility of global and regional strain using strain analysis in ARVC between various commercially available software packages. 15 In 110 subjects (39 overt ARVC, 40 preclinical ARVC, and 31 control), global and regional RV myocardial regional strains were analyzed using 4 softwares (including Multimodality Tissue Tracking-which we used in our present study). BlandAltman analysis showed moderate agreement between the softwares but significant variability on the level of individual measurements given the different strain calculation algorithms. Despite this variability, all softwares were able to identify overt ARVC patients from controls by global and regional strain analysis. Therefore, although absolute strain values are not to be translated from one software to another, the use of feature tracking to measure strain remains a robust method to diagnose regional myocardial dysfunction in ARVC.
LGE Mapping of VT Substrate
Previous studies demonstrated that fibrofatty ventricular scar can be seen as LGE in ARVC patients. 8, 16, 17 Indeed, Tandri et al 8 were the first to report RV-LGE in patients with ARVC and demonstrated its relation to fibrofatty myocardial changes. In our present study, RV segments with LGE demonstrated regional dyskinesia, with lower circumferential strain compared with areas without LGE. Although never reported in ARVC, the inverse relationship between CMR regional strain and LGE was previously demonstrated in LV of patients with cardiac amyloidosis as well as hypertrophic cardiomyopathy. 
18,19
Marra et al
17 studied the correlation of LGE with endocardial EAM in the characterization of ARVCrelated scar. Consistent with our findings, the authors concluded that LGE scars modestly correlated with endocardial EAM, with ≈50% of electric scar in the RV not confirmed by LGE. We also found no agreement between LGE and epicardial EAM scars. Of note, as seen in Table II in the Data Supplement, the OR of LGE scar in prediction of endo/epicardial scar were associated with large confidence intervals demonstrating low precision in these estimates. The limited ability of LGE to characterize electrical abnormalities in the RV has been previously reported by Andrews et al 20 who showed that, in contrast to LV-LGE, RV-LGE did not correlate with electrogram markers of abnormal depolarization such as ECG amplitude (ie, bipolar voltage) and signal fractionation (P=0.76 and P=0.47, respectively). The modest correlation between invasive electroanatomic substrate mapping and LGE has been attributed to the thin wall of the RV (≈3-4 mm) which complicates LGE imaging. The complex pathophysiology of ARVC (fibrofatty replacement of the myocardium) makes LGE imaging in the RV all-the-more challenging. Alternatively, it is possible that electrophysiological abnormalities in the RV manifest in the presence of minimal scar or scar that is diffuse and not easily resolved with current imaging techniques. Also, current LGE sequences are designed such that inversion time is inadequately set to null LV instead of RV myocardium.
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RV Strain Analysis for ARVC Diagnosis
Our work in validating objective/semiautomatic techniques to analyze regional myocardial function is motivated by the known pitfalls of the 2010 TFC for ARVC diagnosis, which rely on visual inspection of RV and may be incorrectly applied in centers lacking experience in ARVC. In a study from a tertiary care center, misdiagnosis of ARVC was common with only 27% of 89 patients seeking a second opinion after receiving an ARVC diagnosis actually meeting TFC on secondary review. 22 Moreover, RV free wall contraction can result in areas of subjective bulging near the moderator band insertion, even in normal patients, which can mimic a wall motion abnormality. 23 Tethering of the RV anterior wall to the back of the sternum, frequently seen at the outflow tract, can mimic a wall motion abnormality. 24 RV size can be increased in athletes and patients with intracardiac shunts, mimicking RV dilation. 25 In all these cases, myocardial function is normal and regional strain analysis would be able to objectively rule out ARVC mimics. In recently published work, we have shown that quantitative strain analysis had higher sensitivity and accuracy than qualitative wall motion assessment done by visual inspection by 2 experts at our tertiary center.
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RV Strain for VT Substrate Mapping
Intracardiac electrophysiological testing has traditionally been used to assess the risk of ventricular arrhythmias, but the prognostic value of VT induced by programmed ventricular stimulation in patients with asymptomatic ARVC remains controversial, particularly in patients with benign-looking imaging. 26, 27 Although physicians still prefer to perform EPS to diagnose ARVC and rule out benign conditions like idiopathic RVOT tachycardia, the invasiveness of the procedure warrants investigating new modalities that do not carry the same inherent risks to the patient. Even in patients with more advanced forms of the disease, this study demonstrates that arrhythmia substrate can be assessed noninvasively using tissue tracking on cine CMR, allowing preprocedural recognition of the spatial distribution of electrophysiological scar and helping to focus mapping on the culprit region as successful ablation sites were found to have lower strain on CMR compared with the rest of the RV. In contrast, LGE magnetic resonance imaging displayed limited agreement with endocardial EAM scar, and no agreement whatsoever with epicardial EAM; thus, in its current state, LGE possesses limited capabilities in comprehensively mapping VT substrate in RV of patients with ARVC.
Limitations
Although ARVC is a relatively common reason for heart evaluation by CMR, the disease is quite rare and the sample size is therefore small. This is a retrospective analysis of 21 patients who, as demonstrated by the number of TFC criteria, have advanced disease leading to clinically significant ventricular arrhythmias. Consequently, the results may not be extrapolated to all ARVC subjects with mild or subclinical disease. The small number of subjects included in the multivariable analyses could also lead to type I error or overfitting. Given the significant artifact created by device leads which would theoretically affect feature-tracking capabilities, and the fact that strain analysis has not been validated as of yet in this setting, we decided to exclude patients with devices at the time of the magnetic resonance imaging, which further limits generalizability of our findings. The temporal gap between scan and procedure (3.6±3.2 months) was not pre-defined. However, our recent report on ARVC progression suggests that RV fractional shortening changes minimally over a period of several years and is unlikely to have resulted in a significant change over a 3-month period. 28 The thin wall of the RV (like that of the atria) makes analysis of wall strain challenging. However, the in-plane axial resolution of our CINE sequence ranged from 0.8 to 1.5 mm per dimension and is thus able to capture and track the 3 to 4 mm thick RV wall throughout the cardiac cycle. The challenges related to the resolution (spatial or temporal) constitute systematic error and would not affect the detection of intersegment variability in wall strain. We relied solely on bipolar voltage values to define dense scar on EAM. This may have led to an overestimation of reported substrate particularly on epicardial mapping because of fat, coronary vasculature, and poor catheter contact.
Conclusions
In patients with ARVC and ventricular arrhythmias, regional wall strain assessed on cine CMR reliably predicts arrhythmogenic VT substrate. This technique allows safe and improved diagnostic accuracy in ARVC, obviating the need for invasive procedures, and facilitates planning of VT ablation procedures. 
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